Cardiac allograft vasculopathy (CAV) is the major determinant of long-term survival after heart transplantation. We aimed to evaluate the efficacy of PET as a noninvasive way to assess the early stages of CAV. Methods: Twenty-seven consecutive patients (20 men and 7 women; mean age 6 SD, 46 6 12 y) who had normal results on coronary angiography and normal left ventricular systolic function (ejection fraction $ 60%) were enrolled at 2.5 6 2.1 y after transplantation. Myocardial blood flow (MBF) was assessed using dynamic 13 N-ammonia PET at rest and during adenosine-induced hyperemia, and myocardial perfusion reserve (MPR) was calculated as the ratio of hyperemic MBF to resting MBF. Regional 13 N-ammonia PET was assessed using a 5-point scoring system. The intravascular ultrasound (IVUS) measurements for the extent of intimal hyperplasia, including plaque volume index (calculated as [total plaque volume/total vessel volume] · 100%) and maximum area of stenosis, were compared with MPR by linear regression analysis. Results: In 27 angiographically normal cardiac transplant recipients, MBF at rest and during adenosine stress and MPR of the left anterior descending artery distribution correlated strongly with the other 2 coronary artery distribution territories (r $ 0.97, P , 0.0001). Summed stress score and summed difference score showed a moderate inverse correlation with MPR (r 5 20.41 and 20.49, respectively; P , 0.05) but not with IVUS measurements. MPR correlated inversely with plaque volume index (r 5 20.40, P , 0.05) but not with maximal luminal stenosis as assessed by IVUS. In addition, MPR and IVUS measurements gradually inversely changed after heart transplantation (all P , 0.05). Conclusion: This study confirms that CAV is a progressive process, diffusely involving the epicardial and microvascular coronary system. Plaque burden as determined by IVUS agrees well with MPR as assessed by PET in recipients with normal coronary angiography results. This finding suggests that dynamic 13 N-ammonia PET is clinically feasible for the early detection of CAV and can be used as a reliable marker of disease progression. Cardi ac allograft vasculopathy (CAV) is one of the leading causes of late mortality after heart transplantation (1,2). Early CAV is clinically silent, and ischemia is usually not evident until the disease is far advanced. The traditional annual coronary angiogram for surveillance is of limited value because CAV is characterized by diffuse concentric intimal thickening of both epicardial and intramyocardial arteries and may thus be overlooked on a coronary angiogram. Intravascular ultrasound (IVUS) has been proposed to be the most sensitive method for diagnosis of early CAV (3-8). However, the invasiveness and the physical bulkiness of IVUS catheters make the widespread application of IVUS in the detection of CAV difficult (2-5).Stress myocardial perfusion images, including SPECT and PET, have been recognized as key diagnostic methods to evaluate coronary artery disease (9-12). Stress myocardial SPECT,...